🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Box Office: 'The Marksman' Captures Top Spot With $2 Million, Bleak Times for Movie Theaters

Published 2021-01-24, 01:12 p/m
© Reuters.

By Brent Lang

LOS ANGELES, Jan 24, (Variety.com) - Pray for movie theaters.

"The Marksman," a Liam Neeson thriller from Open Road, held onto first place for the second weekend in a row, grossing just over $2 million. The film has grossed $61 million after 10 days of release.

That performance allows the movie to retain its box office crown, but that kind of distinction isn't worth what it was in pre-pandemic times, particularly with movie theaters closed indefinitely in major markets like New York City and Los Angeles.

Indeed, the exhibition landscape is a wasteland and with the vaccine rollout hampered by a lack of, you know, vaccines, help could be in short supply. There's little that portends a rapid recovery for a sector of the economy that's been decimated by the public health crisis. Last week, MGM yielded to the inevitable and pushed the release of its James Bond sequel, "No Time to Die," from April to Oct. 8. The film was initially intended to debut in spring of 2020 before COVID-19 upended daily life.

Bond's move prompted a flurry of release date shifts, with the likes of "Morbius," "Ghostbusters Afterlife," "Cinderella," and "A Quiet Place Part II" all moving to later in the year in the hopes of outrunning a pandemic that keeps killing people at an alarming rate. At the same time, Adam Aron, CEO of AMC, the dangerously leveraged exhibitor that has teetered on the verge of financial ruin for much of coronavirus, sat for a lengthy profile with the New York Times, in which he sought to reassure Wall Street that the theater chain would renegotiate its debt and recapitalize (again) in order to ride out the plague. There's a lot more track for Aron and his exhibition brethren to tackle before COVID is behind them.

Here's how the rest of the pack fared. DreamWorks Animation's "The Croods: A New Age" grossed $1.8 million in its ninth week of release, pushing its domestic haul to $41.8 million. Internationally, film took in $1.6 million in 17 territories, bringing its global total to $139.8 million.

Warner Bros.' "Wonder Woman 1984" netted $1.6 million domestically. The superhero sequel debuted simultaneously on HBO Max in an effort to drive subscribers to the WarnerMedia streaming service. Internationally, "Wonder Woman 1984" picked up $2.1 million. The film's global haul stands at $148 million.

Sony Pictures' "Monster Hunter," a film adaptation of a popular video game, grossed $820,000 and has a domestic gross of $10.2 million.

Universal's "News of the World," a Western with Tom Hanks that is also available on PVOD, earned $810,000. The film has grossed $9.6 million domestically after five weeks of release.

Lionsgate's "Fatale," a psychological thriller with Hilary Swank, grossed $415,000. It has a domestic gross of $5.3 million after just over a month in theaters.

Focus Features' "Promising Young Woman" took in $400,000, pushing its gross to $4 million. Both "The Croods" sequel and "Promising Young Woman" are available on PVOD, part of parent studio Universal's deal with exhibitors to release movies in theaters in return for allowing them to debut on-demand within weeks of their big screen bows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.